FDA Drug Shortages

Current and Resolved Drug Shortages and Discontinuations Reported to FDA

Start Over | Back to Previous Screen

Dorzolamide Hydrochloride and Timolol Maleate (Cosopt) Ophthalmic Solution
Status: Discontinuation
»Therapeutic Categories: Ophthalmology

Teva Pharmaceuticals (New 04/20/2018)

Company Contact Information:

Presentation Posting Date Related Information
Dorzolamide Hydrochloride and Timolol Maleate 20 mg and 5 mg/mL, 10 mL (0591-2482-79) 04/20/2018 This was a business-related decision to discontinue manufacturing this product.

Note: If you need help accessing information in different file formats, see Instructions for Downloading Viewers and Players.
Language Assistance Available: Español | 繁體中文 | Tiếng Việt | 한국어 | Tagalog | Русский | العربية | Kreyòl Ayisyen | Français | Polski | Português | Italiano | Deutsch | 日本語 | فارسی | English